| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Aug 24 | FATE Fate Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 4.23 | 633 | 2.68 k | 8,669 |
| 14 Jun 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.02 | 25,000 | 25.50 k | 25,000 |
| 8 Jun 24 | AKRO Akero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 26,000 | 598.52 k | 26,000 |
| 7 Jun 24 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.68 | 40,000 | 147.20 k | 40,000 |
| 4 Aug 23 | FATE Fate Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 3.71 | 632 | 2.34 k | 9,302 |
